A research team at Majmaah University, with a number of researchers from the health and medical sectors in the Kingdom, has invented an antibody used as a preventive treatment for Alzheimer's disease.
The research, which lasted three years- consisted of a number of researchers with various specialties led by Dr. Raed Salim ElBaradei- Associate Professor and Consultant of Pathology at the College of Applied Medical Sciences, Majmaah University, Dr. Yasser Baabeer from the General Directorate of Medical Services, Armed Forces, Dr. Abdurrahman Al-Suleiman from King Fahad Medical City, Dr. Ali Al-Shankaiti from King Abdul-Aziz University, Dr. Ayman al-Jawhari, Dr. Meshaal Fanisan, Dr. Bader Al-Shihri, Head of Laboratory and Immunology Counselor from Majmaah University, Dr. Ahmed Al-Thubaiti and Dr. Khalid Al-Ramah and Dr. Mark Anthony Slaven, Head of the Research Center at the University of Manchester Metropolitan in Britain.
The research has been through 3 phases:
Phase I: Identification and detection of the protein that causes the symptoms of Alzheimer's.
Phase II: Designing and producing an antibody that has the ability to prevent the deposition of the mono-CRP protein causing Alzheimer's disease.
Phase III: Developing the antibody to bind to the protein, change it and prevent its deposition, which causes the symptoms of Alzheimer's disease.
During each phase, the results were published in international refereed journals.
The research team participated in the Medical Laboratories Conference held in Riyadh on 11-13-1440 and received a silver shield from the organizer of the exhibition.
The team thanked MU Rector and the Vice-Rector for Research for their support of the achievement.